Dynamic Technology Lab’s Cytek Biosciences CTKB Stock Holding History

Dynamic Technology Lab’s Portfolio CTKB Stock Details CTKB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$64.6K	Sell	14,778 -29,496	-67%	-$139K	0.01%	809
2025 Q4	$224K	Buy	44,274 +9,155	+26%	+$42.5K	0.05%	588
2025 Q3	$122K	Sell	35,119 -10,595	-23%	-$39.8K	0.02%	716
2025 Q2	$155K	Buy	45,714 +32,427	+244%	+$108K	0.02%	827
2025 Q1	$53K	Sell	13,287 -11,136	-46%	-$57.7K	0.01%	928
2024 Q4	$159K	Sell	24,423 -3,580	-13%	-$21.3K	0.03%	790
2024 Q3	$155K	Buy	28,003 +4,533	+19%	+$25.7K	0.02%	912
2024 Q2	$131K	Buy	23,470 +6,524	+38%	+$39.2K	0.01%	836
2024 Q1	$114K	Buy	+16,946	New	+$134K	0.01%	961
2023 Q2	–	Sell	-13,581	Closed	-$125K	–	1065
2023 Q1	$125K	Buy	+13,581	New	+$146K	0.01%	956

Other funds holding CTKB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dynamic Technology Lab's CTKB Position: Q1 2026 in Review

Dynamic Technology Lab reduced its Cytek Biosciences (CTKB) stake by 67% in Q1 2026, selling an estimated $139K and leaving 14,778 shares worth $64.6K. The position accounts for 0.01% of the portfolio, ranked #809.

Dynamic Technology Lab first reported a position in CTKB in Q1 2023 and has held it in 10 quarters since. The position peaked at $224K in Q4 2025. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

Dynamic Technology Lab held 14,778 shares of Cytek Biosciences worth $64.6K as of Q1 2026.
Dynamic Technology Lab sold 29,496 Cytek Biosciences shares in Q1 2026, an estimated $139K.
Cytek Biosciences made up 0.01% of Dynamic Technology Lab's portfolio in Q1 2026, its #809 holding.
Dynamic Technology Lab first reported a position in Cytek Biosciences in Q1 2023 and has held it in 10 quarters since.
Dynamic Technology Lab's Cytek Biosciences position peaked at $224K in Q4 2025.
165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.